Tag: Therapeutics

Xilio Therapeutics press release (XLO): Q1 Revenue of $12.6M. Net Loss: Net loss was $9.5 million for the quarter ended March 31, ...

Riding the sector wave. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) surged 7.0% to $104.39 on Tuesday, April 14, 2026, as a ...

Loss Per Share (GAAP) $0.26 Loss narrows sharply. Dogwood Therapeutics, Inc. (NASDAQ: DWTX) reported a loss of $0.26 per share ...

Earnings Per Share (GAAP) $-0.06 vs $-0.10 est. (narrower loss, 37.2%) Loss narrows sharply. Trevi Therapeutics, Inc. (NASDAQ: TRVI) reported ...

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...

The US FDA has issued a Complete Response Letter to Outlook Therapeutics (OTLK) for its resubmitted Biologics License Application for ...

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the “Contrarius Global Equity Fund”. A copy ...

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, ...

Israeli biopharmaceutical company Syremis Therapeutics, which is developing medicines for mental health conditions, has announced the completion of a ...